AP2008004468A0 - Pyrazine derivatives as sodium channel modulators for the treatment of pain - Google Patents

Pyrazine derivatives as sodium channel modulators for the treatment of pain

Info

Publication number
AP2008004468A0
AP2008004468A0 AP2008004468A AP2008004468A AP2008004468A0 AP 2008004468 A0 AP2008004468 A0 AP 2008004468A0 AP 2008004468 A AP2008004468 A AP 2008004468A AP 2008004468 A AP2008004468 A AP 2008004468A AP 2008004468 A0 AP2008004468 A0 AP 2008004468A0
Authority
AP
ARIPO
Prior art keywords
pain
treatment
sodium channel
channel modulators
pyrazine derivatives
Prior art date
Application number
AP2008004468A
Other languages
English (en)
Inventor
Cedric Poinsard
Stephen Martin Denton
Karl Richard Et Al Gibson
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of AP2008004468A0 publication Critical patent/AP2008004468A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AP2008004468A 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain AP2008004468A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73366205P 2005-11-04 2005-11-04
PCT/IB2006/003055 WO2007052123A2 (en) 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain

Publications (1)

Publication Number Publication Date
AP2008004468A0 true AP2008004468A0 (en) 2008-06-30

Family

ID=37890558

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004468A AP2008004468A0 (en) 2005-11-04 2006-10-23 Pyrazine derivatives as sodium channel modulators for the treatment of pain

Country Status (27)

Country Link
US (1) US7572797B2 (de)
EP (1) EP1945630B1 (de)
JP (1) JP2009514937A (de)
KR (1) KR20080066073A (de)
CN (1) CN101356169A (de)
AP (1) AP2008004468A0 (de)
AR (1) AR057855A1 (de)
AT (1) ATE525372T1 (de)
AU (1) AU2006310215A1 (de)
BR (1) BRPI0618129A2 (de)
CA (1) CA2624621C (de)
CR (1) CR9954A (de)
DO (1) DOP2006000243A (de)
EA (1) EA200801011A1 (de)
EC (1) ECSP088412A (de)
ES (1) ES2371932T3 (de)
GT (1) GT200600475A (de)
IL (1) IL191059A0 (de)
MA (1) MA29926B1 (de)
NL (1) NL2000284C2 (de)
NO (1) NO20082496L (de)
PE (1) PE20070715A1 (de)
TN (1) TNSN08196A1 (de)
TW (1) TW200804353A (de)
UY (1) UY29893A1 (de)
WO (1) WO2007052123A2 (de)
ZA (1) ZA200803671B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
EP1741708A1 (de) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl substituierte Amide mit ungesättigtem oder zyklischem Linker, und deren Verwendung als Pharmaka
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
CA2684105C (en) 2007-05-03 2011-09-06 Pfizer Limited Pyridine derivatives
WO2008135830A1 (en) * 2007-05-03 2008-11-13 Pfizer Limited N- [6-amino-s- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
US8614255B2 (en) * 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
CL2008003651A1 (es) 2007-12-10 2009-06-19 Novartis Ag Compuestos derivados de 3,5-diamino-6-cloropirazinamida sustituida; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de una condición inflamatoria o alergica, en particular una enfermedad inflamatoria u obstructiva de las vias respiratorias.
KR20100124262A (ko) 2008-02-13 2010-11-26 에자이 알앤드디 매니지먼트 가부시키가이샤 비시클로아민 유도체
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
US10703722B2 (en) 2010-04-27 2020-07-07 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (en) * 2011-10-19 2013-04-25 Calcimedica, Inc. Compounds that modulate intracellular calcium
MX360323B (es) 2012-04-25 2018-10-29 Raqualia Pharma Inc Derivados de pirrolopiridinona como bloqueadores de ttx-s.
US9079866B2 (en) 2013-02-04 2015-07-14 Janssen Pharmaceutica Nv Flap modulators
TWI644899B (zh) 2013-02-04 2018-12-21 健生藥品公司 Ｆｌａｐ調節劑
JP2017526706A (ja) * 2014-09-10 2017-09-14 エピザイム，インコーポレイティド イソオキサゾールカルボキサミド化合物
EP3778595B1 (de) 2015-02-27 2021-08-25 Calcimedica, Inc. Pankreatitisbehandlung
CA2995094A1 (en) 2015-08-07 2017-02-16 Calcimedica, Inc. Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds
JP2023528537A (ja) 2020-03-20 2023-07-04 カルシメディカ，インク． 急性肺傷害及び急性呼吸窮迫症候群を処置するための方法及び組成物
CA3198798A1 (en) 2020-11-13 2022-05-19 Kenneth Stauderman Improved synthesis of crac channel inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA26473A1 (fr) * 1997-03-01 2004-12-20 Glaxo Group Ltd Composes pharmacologiquement actifs.
BR0214309A (pt) * 2001-11-21 2004-10-13 Upjohn Co Derivados aril-1,4-pirazina substituìdos
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2543644A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Pyrazine derivatives and pharmaceutical use thereof
WO2006047504A1 (en) * 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Aromatic amides as inhibitors of c-fms kinase

Also Published As

Publication number Publication date
AU2006310215A1 (en) 2007-05-10
WO2007052123A2 (en) 2007-05-10
GT200600475A (es) 2007-07-06
WO2007052123A3 (en) 2007-07-12
US7572797B2 (en) 2009-08-11
JP2009514937A (ja) 2009-04-09
CR9954A (es) 2008-05-28
BRPI0618129A2 (pt) 2011-08-16
EP1945630B1 (de) 2011-09-21
NO20082496L (no) 2008-07-24
TW200804353A (en) 2008-01-16
PE20070715A1 (es) 2007-08-11
KR20080066073A (ko) 2008-07-15
UY29893A1 (es) 2007-06-29
ATE525372T1 (de) 2011-10-15
ES2371932T3 (es) 2012-01-11
CA2624621A1 (en) 2007-05-10
CA2624621C (en) 2010-11-30
TNSN08196A1 (fr) 2009-10-30
DOP2006000243A (es) 2007-05-31
ECSP088412A (es) 2008-05-30
AR057855A1 (es) 2007-12-19
IL191059A0 (en) 2008-12-29
EP1945630A2 (de) 2008-07-23
ZA200803671B (en) 2009-03-25
NL2000284A1 (nl) 2007-05-07
MA29926B1 (fr) 2008-11-03
CN101356169A (zh) 2009-01-28
US20070105872A1 (en) 2007-05-10
EA200801011A1 (ru) 2009-02-27
NL2000284C2 (nl) 2007-09-28

Similar Documents

Publication Publication Date Title
IL191059A0 (en) Pyrazine derivatives as sodium channel modulators for the treatment of pain
IL191832A0 (en) Pyridiazinone derivatives for the treatment of tumours
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
SI2024368T1 (sl) Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL188430A0 (en) Treatment of tumors
IL192627A0 (en) Prolinamide derivatives as sodium channel modulators
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
GB0715745D0 (en) Liquid formulations for treatment of diseases or conditions
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
EP1928452A4 (de) Verwendung von natriumkanalblockern zur behanldung von viszeralen schmerzen oder schmerzen durch krebsbehandlung
GB0909297D0 (en) Composition for the treatment of skin conditions
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP1867640A4 (de) Mittel zur behandlung fester tumore
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
EP1871372A4 (de) Kombinationstherapie mit einem calciumkanalblocker vom n-typ zur schmerzminderung
GB0517387D0 (en) Combinations for the treatment of cancer
ZA200802879B (en) Prolinamide derivatives as sodium channel modulators
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
EP1900363A4 (de) Therapeutisches mittel gegen schmerzen
GB0505203D0 (en) Skin composition treatment
HUP0500947A2 (en) Composition for treatment of paradontosis
HK1122032A (en) Benzoisoindole derivatives for the treatment of pain
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
GB0517386D0 (en) Combinations for the treatment of cancer
HK1110796A (en) Treatment of tumors